|
Originally published In Press as doi:10.1074/jbc.M106340200 on August 16, 2001
J. Biol. Chem., Vol. 276, Issue 42, 39411-39418, October 19, 2001
Disrupted Bile Acid Homeostasis Reveals an Unexpected Interaction
among Nuclear Hormone Receptors, Transporters, and Cytochrome P450*
Erin G.
Schuetz ,
Stephen
Strom§,
Kazuto
Yasuda ,
Valerie
Lecureur ,
Mahfoud
Assem ,
Cynthia
Brimer ,
Jatinder
Lamba ,
Richard B.
Kim¶,
Vinod
Ramachandran ,
Bernard J.
Komoroski ,
Raman
Venkataramanan§ ,
Hongbo
Cai§,
Christopher J.
Sinal**,
Frank J.
Gonzalez**, and
John D.
Schuetz 
From the Department of Pharmaceutical
Sciences, St. Jude Children's Research Hospital,
Memphis, Tennessee 38105, the Departments of § Pathology
and Pharmaceutical Sciences, the University of Pittsburgh,
Pittsburgh, Pennsylvania 15261, the ¶ Department of
Pharmacology, Vanderbilt University, Nashville, Tennessee 37203, and
the ** Laboratory of Medicine, National Institutes of Health,
Bethesda, Maryland 20892
Sister of P-glycoprotein (SPGP) is
the major hepatic bile salt export pump (BSEP). BSEP/SPGP expression
varies dramatically among human livers. The potency and hierarchy of
bile acids as ligands for the farnesyl/bile acid receptor (FXR/BAR)
paralleled their ability to induce BSEP in human hepatocyte cultures.
FXR:RXR heterodimers bound to IR1 elements and enhanced bile acid
transcriptional activation of the mouse and human BSEP/SPGP promoters.
In FXR/BAR nullizygous mice, which have dramatically reduced BSEP/SPGP
levels, hepatic CYP3A11 and CYP2B10 were strongly but unexpectedly
induced. Notably, the rank order of bile acids as CYP3A4 inducers and
activators of pregnane X receptor/steroid and xenobiotic receptor
(PXR/SXR) closely paralleled each other but was markedly different from their hierarchy and potency as inducers of BSEP in human hepatocytes. Moreover, the hepatoprotective bile acid ursodeoxycholic acid, which
reverses hydrophobic bile acid hepatotoxicity, activates PXR and
efficaciously induces CYP3A4 (a bile-metabolizing enzyme) in primary
human hepatocytes thus providing one mechanism for its
hepatoprotection. Because serum and urinary bile acids increased in
FXR/BAR / mice, we evaluated hepatic transporters for compensatory changes that might circumvent the profound decrease in BSEP/SPGP. We
found weak MRP3 up-regulation. In contrast, MRP4 was substantially increased in the FXR/BAR nullizygous mice and was further elevated by
cholic acid. Thus, enhanced hepatocellular concentrations of bile
acids, due to the down-regulation of BSEP/SPGP-mediated efflux in FXR
nullizygous mice, result in an alternate but apparent compensatory up-regulation of CYP3A, CYP2B, and some ABC transporters that is
consistent with activation of PXR/SXR by bile acids.
*
This work was supported by National Institutes of Health
Research Grants GM60346, ES08648, ES058571, ES08648, ES05780, and P30
CA21745, Cancer Center support grant, the American Lebanese Syrian
Associated Charities, and Grant DK92310.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.

To whom correspondence should be addressed: Dept. of
Pharmaceutical Sciences, St. Jude Children's Research Hospital, 332 N. Lauderdale Ave., Memphis, TN 38105. Tel.: 901-495-2174; Fax:
901-525-6869; E-mail: John.schuetz@stjude.org.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. Hariparsad, X. Chu, J. Yabut, P. Labhart, D. P. Hartley, X. Dai, and R. Evers
Identification of pregnane-X receptor target genes and coactivator and corepressor binding to promoter elements in human hepatocytes
Nucleic Acids Res.,
March 1, 2009;
37(4):
1160 - 1173.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. B. Hartman, K. Lai, and M. J. Evans
Loss of small heterodimer partner expression in the liver protects against dyslipidemia
J. Lipid Res.,
February 1, 2009;
50(2):
193 - 203.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Kis, Z. Rajnai, E. Ioja, K. Heredi Szabo, T. Nagy, D. Mehn, and P. Krajcsi
Mouse Bsep ATPase Assay: A Nonradioactive Tool for Assessment of the Cholestatic Potential of Drugs
J Biomol Screen,
January 1, 2009;
14(1):
10 - 15.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. I. Mackenzie, A. Rogers, J. Treloar, B. R. Jorgensen, J. O. Miners, and R. Meech
Identification of UDP Glycosyltransferase 3A1 as a UDP N-Acetylglucosaminyltransferase
J. Biol. Chem.,
December 26, 2008;
283(52):
36205 - 36210.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Cheng and C. D. Klaassen
Perfluorocarboxylic Acids Induce Cytochrome P450 Enzymes in Mouse Liver through Activation of PPAR-{alpha} and CAR Transcription Factors
Toxicol. Sci.,
November 1, 2008;
106(1):
29 - 36.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Eloranta and G. A. Kullak-Ublick
The Role of FXR in Disorders of Bile Acid Homeostasis
Physiology,
October 1, 2008;
23(5):
286 - 295.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Matsubara, K. Yoshinari, K. Aoyama, M. Sugawara, Y. Sekiya, K. Nagata, and Y. Yamazoe
Role of Vitamin D Receptor in the Lithocholic Acid-Mediated CYP3A Induction in Vitro and in Vivo
Drug Metab. Dispos.,
October 1, 2008;
36(10):
2058 - 2063.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Callaghan, E. Crowley, S. Potter, and I. D. Kerr
P-glycoprotein: So Many Ways to Turn It On
J. Clin. Pharmacol.,
March 1, 2008;
48(3):
365 - 378.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Wagner, G. Zollner, P. Fickert, J. Gumhold, D. Silbert, A. Fuchsbichler, J. S. Gujral, K. Zatloukal, H. Denk, H. Jaeschke, et al.
Hepatobiliary Transporter Expression in Intercellular Adhesion Molecule 1 Knockout and Fas Receptor-Deficient Mice after Common Bile Duct Ligation Is Independent of the Degree of Inflammation and Oxidative Stress
Drug Metab. Dispos.,
September 1, 2007;
35(9):
1694 - 1699.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Marzolini, R. G. Tirona, G. Gervasini, B. Poonkuzhali, M. Assem, W. Lee, B. F. Leake, J. D. Schuetz, E. G. Schuetz, and R. B. Kim
A Common Polymorphism in the Bile Acid Receptor Farnesoid X Receptor Is Associated with Decreased Hepatic Target Gene Expression
Mol. Endocrinol.,
August 1, 2007;
21(8):
1769 - 1780.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Li, O. Mezei, and N. F. Shay
Human and Murine Hepatic Sterol-12-{alpha}-Hydroxylase and Other Xenobiotic Metabolism mRNA Are Upregulated by Soy Isoflavones
J. Nutr.,
July 1, 2007;
137(7):
1705 - 1712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. G. Woods, J. P. Vanden Heuvel, and I. Rusyn
Genomic Profiling in Nuclear Receptor-Mediated Toxicity
Toxicol Pathol,
June 1, 2007;
35(4):
474 - 494.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Zamek-Gliszczynski, K.-i. Nezasa, X. Tian, A. S. Bridges, K. Lee, M. G. Belinsky, G. D. Kruh, and K. L. R. Brouwer
Evaluation of the Role of Multidrug Resistance-Associated Protein (Mrp) 3 and Mrp4 in Hepatic Basolateral Excretion of Sulfate and Glucuronide Metabolites of Acetaminophen, 4-Methylumbelliferone, and Harmol in Abcc3-/- and Abcc4-/- Mice
J. Pharmacol. Exp. Ther.,
December 1, 2006;
319(3):
1485 - 1491.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. W. Joyce, E. M. Wagner, F. Basso, M. J. Amar, L. A. Freeman, R. D. Shamburek, C. L. Knapper, J. Syed, J. Wu, B. L. Vaisman, et al.
ABCA1 Overexpression in the Liver of LDLr-KO Mice Leads to Accumulation of Pro-atherogenic Lipoproteins and Enhanced Atherosclerosis
J. Biol. Chem.,
November 3, 2006;
281(44):
33053 - 33065.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Jung, D. J. Mangelsdorf, and U. A. Meyer
Pregnane X Receptor Is a Target of Farnesoid X Receptor
J. Biol. Chem.,
July 14, 2006;
281(28):
19081 - 19091.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. G. Deeley, C. Westlake, and S. P. C. Cole
Transmembrane Transport of Endo- and Xenobiotics by Mammalian ATP-Binding Cassette Multidrug Resistance Proteins.
Physiol Rev,
July 1, 2006;
86(3):
849 - 899.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Li and J. Y. L. Chiang
RIFAMPICIN INDUCTION OF CYP3A4 REQUIRES PREGNANE X RECEPTOR CROSS TALK WITH HEPATOCYTE NUCLEAR FACTOR 4{alpha} AND COACTIVATORS, AND SUPPRESSION OF SMALL HETERODIMER PARTNER GENE EXPRESSION
Drug Metab. Dispos.,
May 1, 2006;
34(5):
756 - 764.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-Y. Chu, J. R. Strauss, M. A. Mariano, J. Li, D. J. Newton, X. Cai, R. W. Wang, J. Yabut, D. P. Hartley, D. C. Evans, et al.
Characterization of Mice Lacking the Multidrug Resistance Protein Mrp2 (Abcc2)
J. Pharmacol. Exp. Ther.,
May 1, 2006;
317(2):
579 - 589.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Moffit, L. M. Aleksunes, J. M. Maher, G. L. Scheffer, C. D. Klaassen, and J. E. Manautou
Induction of Hepatic Transporters Multidrug Resistance-Associated Proteins (Mrp) 3 and 4 by Clofibrate Is Regulated by Peroxisome Proliferator-Activated Receptor {alpha}
J. Pharmacol. Exp. Ther.,
May 1, 2006;
317(2):
537 - 545.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Zollner, M. Wagner, T. Moustafa, P. Fickert, D. Silbert, J. Gumhold, A. Fuchsbichler, E. Halilbasic, H. Denk, H.-U. Marschall, et al.
Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-{alpha}/beta in the adaptive response to bile acids
Am J Physiol Gastrointest Liver Physiol,
May 1, 2006;
290(5):
G923 - G932.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. M. Johnson, P. Zhang, J. D. Schuetz, and K. L. R. Brouwer
CHARACTERIZATION OF TRANSPORT PROTEIN EXPRESSION IN MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) 2-DEFICIENT RATS
Drug Metab. Dispos.,
April 1, 2006;
34(4):
556 - 562.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Rius, J. Hummel-Eisenbeiss, A. F. Hofmann, and D. Keppler
Substrate specificity of human ABCC4 (MRP4)-mediated cotransport of bile acids and reduced glutathione
Am J Physiol Gastrointest Liver Physiol,
April 1, 2006;
290(4):
G640 - G649.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-U. Marschall, M. Wagner, K. Bodin, G. Zollner, P. Fickert, J. Gumhold, D. Silbert, A. Fuchsbichler, J. Sjovall, and M. Trauner
Fxr-/- mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acids
J. Lipid Res.,
March 1, 2006;
47(3):
582 - 592.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-F. Landrier, J. J. Eloranta, S. R. Vavricka, and G. A. Kullak-Ublick
The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-{alpha} and -beta genes
Am J Physiol Gastrointest Liver Physiol,
March 1, 2006;
290(3):
G476 - G485.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Fickert, A. Fuchsbichler, H.-U. Marschall, M. Wagner, G. Zollner, R. Krause, K. Zatloukal, H. Jaeschke, H. Denk, and M. Trauner
Lithocholic Acid Feeding Induces Segmental Bile Duct Obstruction and Destructive Cholangitis in Mice
Am. J. Pathol.,
February 1, 2006;
168(2):
410 - 422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Lee, Y. Zhang, F. Y. Lee, S. F. Nelson, F. J. Gonzalez, and P. A. Edwards
FXR regulates organic solute transporters {alpha} and {alpha} in the adrenal gland, kidney, and intestine
J. Lipid Res.,
January 1, 2006;
47(1):
201 - 214.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Hanniman, G. Lambert, T. C. McCarthy, and C. J. Sinal
Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice
J. Lipid Res.,
December 1, 2005;
46(12):
2595 - 2604.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. K. Wolf, S. G. Wood, J. A. Hunt, B. W. Walton-Strong, K. Yasuda, L. Lan, S. X. Duan, Q. Hao, S. A. Wrighton, E. H. Jeffery, et al.
ROLE OF THE NUCLEAR RECEPTOR PREGNANE X RECEPTOR IN ACETAMINOPHEN HEPATOTOXICITY
Drug Metab. Dispos.,
December 1, 2005;
33(12):
1827 - 1836.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Masson, L. Lagrost, A. Athias, P. Gambert, C. Brimer-Cline, L. Lan, J. D. Schuetz, E. G. Schuetz, and M. Assem
Expression of the Pregnane X Receptor in Mice Antagonizes the Cholic Acid-Mediated Changes in Plasma Lipoprotein Profile
Arterioscler. Thromb. Vasc. Biol.,
October 1, 2005;
25(10):
2164 - 2169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Krasowski, K. Yasuda, L. R. Hagey, and E. G. Schuetz
Evolution of the Pregnane X Receptor: Adaptation to Cross-Species Differences in Biliary Bile Salts
Mol. Endocrinol.,
July 1, 2005;
19(7):
1720 - 1739.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Sonoda, L. W. Chong, M. Downes, G. D. Barish, S. Coulter, C. Liddle, C.-H. Lee, and R. M. Evans
Pregnane X receptor prevents hepatorenal toxicity from cholesterol metabolites
PNAS,
February 8, 2005;
102(6):
2198 - 2203.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Miyata, A. Tozawa, H. Otsuka, T. Nakamura, K. Nagata, F. J. Gonzalez, and Y. Yamazoe
Role of Farnesoid X Receptor in the Enhancement of Canalicular Bile Acid Output and Excretion of Unconjugated Bile Acids: A Mechanism for Protection against Cholic Acid-Induced Liver Toxicity
J. Pharmacol. Exp. Ther.,
February 1, 2005;
312(2):
759 - 766.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ananthanarayanan, S. Li, N. Balasubramaniyan, F. J. Suchy, and M. J. Walsh
Ligand-dependent Activation of the Farnesoid X-receptor Directs Arginine Methylation of Histone H3 by CARM1
J. Biol. Chem.,
December 24, 2004;
279(52):
54348 - 54357.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Jedlitschky, K. Tirschmann, L. E. Lubenow, H. K. Nieuwenhuis, J. W. N. Akkerman, A. Greinacher, and H. K. Kroemer
The nucleotide transporter MRP4 (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage
Blood,
December 1, 2004;
104(12):
3603 - 3610.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bhalla, C. Ozalp, S. Fang, L. Xiang, and J. K. Kemper
Ligand-activated Pregnane X Receptor Interferes with HNF-4 Signaling by Targeting a Common Coactivator PGC-1{alpha}: FUNCTIONAL IMPLICATIONS IN HEPATIC CHOLESTEROL AND GLUCOSE METABOLISM
J. Biol. Chem.,
October 22, 2004;
279(43):
45139 - 45147.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Assem, E. G. Schuetz, M. Leggas, D. Sun, K. Yasuda, G. Reid, N. Zelcer, M. Adachi, S. Strom, R. M. Evans, et al.
Interactions between Hepatic Mrp4 and Sult2a as Revealed by the Constitutive Androstane Receptor and Mrp4 Knockout Mice
J. Biol. Chem.,
May 21, 2004;
279(21):
22250 - 22257.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Stedman, G. Robertson, S. Coulter, and C. Liddle
Feed-forward Regulation of Bile Acid Detoxification by CYP3A4: STUDIES IN HUMANIZED TRANSGENIC MICE
J. Biol. Chem.,
March 19, 2004;
279(12):
11336 - 11343.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Echchgadda, C. S. Song, A. K. Roy, and B. Chatterjee
Dehydroepiandrosterone Sulfotransferase Is a Target for Transcriptional Induction by the Vitamin D Receptor
Mol. Pharmacol.,
March 1, 2004;
65(3):
720 - 729.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Handschin and U. A. Meyer
Induction of Drug Metabolism: The Role of Nuclear Receptors
Pharmacol. Rev.,
December 1, 2003;
55(4):
649 - 673.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. L. Guo, G. Lambert, M. Negishi, J. M. Ward, H. B. Brewer Jr., S. A. Kliewer, F. J. Gonzalez, and C. J. Sinal
Complementary Roles of Farnesoid X Receptor, Pregnane X Receptor, and Constitutive Androstane Receptor in Protection against Bile Acid Toxicity
J. Biol. Chem.,
November 14, 2003;
278(46):
45062 - 45071.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Teng, V. Jekerle, and M. Piquette-Miller
INDUCTION OF ABCC3 (MRP3) BY PREGNANE X RECEPTOR ACTIVATORS
Drug Metab. Dispos.,
November 1, 2003;
31(11):
1296 - 1299.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Hata, P. Wang, N. Eftychiou, M. Ananthanarayanan, A. Batta, G. Salen, K. S. Pang, and A. W. Wolkoff
Substrate specificities of rat oatp1 and ntcp: implications for hepatic organic anion uptake
Am J Physiol Gastrointest Liver Physiol,
November 1, 2003;
285(5):
G829 - G839.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kok, C. V. Hulzebos, H. Wolters, R. Havinga, L. B. Agellon, F. Stellaard, B. Shan, M. Schwarz, and F. Kuipers
Enterohepatic Circulation of Bile Salts in Farnesoid X Receptor-deficient Mice: EFFICIENT INTESTINAL BILE SALT ABSORPTION IN THE ABSENCE OF ILEAL BILE ACID-BINDING PROTEIN
J. Biol. Chem.,
October 24, 2003;
278(43):
41930 - 41937.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Ourlin, F. Lasserre, T. Pineau, J. M. Fabre, A. Sa-Cunha, P. Maurel, M.-J. Vilarem, and J. M. Pascussi
The Small Heterodimer Partner Interacts with the Pregnane X Receptor and Represses Its Transcriptional Activity
Mol. Endocrinol.,
September 1, 2003;
17(9):
1693 - 1703.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J E Ros, T A D Roskams, M Geuken, R Havinga, P L Splinter, B E Petersen, N F LaRusso, D M van der Kolk, F Kuipers, K N Faber, et al.
ATP binding cassette transporter gene expression in rat liver progenitor cells
Gut,
July 1, 2003;
52(7):
1060 - 1067.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
E. J. Sanchez Pozzi, F. A. Crocenzi, J. M. Pellegrino, V. A. Catania, M. G. Luquita, M. G. Roma, E. A. R. Garay, and A. D. Mottino
Ursodeoxycholate Reduces Ethinylestradiol Glucuronidation in the Rat: Role in Prevention of Estrogen-Induced Cholestasis
J. Pharmacol. Exp. Ther.,
July 1, 2003;
306(1):
279 - 286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Rosenfeld, R. Vargas Jr., W. Xie, and R. M. Evans
Genetic Profiling Defines the Xenobiotic Gene Network Controlled by the Nuclear Receptor Pregnane X Receptor
Mol. Endocrinol.,
July 1, 2003;
17(7):
1268 - 1282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Westlind-Johnsson, S. Malmebo, A. Johansson, C. Otter, T. B. Andersson, I. Johansson, R. J. Edwards, A. R. Boobis, and M. Ingelman-Sundberg
COMPARATIVE ANALYSIS OF CYP3A EXPRESSION IN HUMAN LIVER SUGGESTS ONLY A MINOR ROLE FOR CYP3A5 IN DRUG METABOLISM
Drug Metab. Dispos.,
June 1, 2003;
31(6):
755 - 761.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kitada, M. Miyata, T. Nakamura, A. Tozawa, W. Honma, M. Shimada, K. Nagata, C. J. Sinal, G. L. Guo, F. J. Gonzalez, et al.
Protective Role of Hydroxysteroid Sulfotransferase in Lithocholic Acid-induced Liver Toxicity
J. Biol. Chem.,
May 9, 2003;
278(20):
17838 - 17844.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Trauner and J. L. Boyer
Bile Salt Transporters: Molecular Characterization, Function, and Regulation
Physiol Rev,
April 1, 2003;
83(2):
633 - 671.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Y. L. Chiang
Bile Acid Regulation of Hepatic Physiology: III. Bile acids and nuclear receptors
Am J Physiol Gastrointest Liver Physiol,
March 1, 2003;
284(3):
G349 - G356.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kawana, T. Ikuta, Y. Kobayashi, O. Gotoh, K. Takeda, and K. Kawajiri
Molecular Mechanism of Nuclear Translocation of an Orphan Nuclear Receptor, SXR
Mol. Pharmacol.,
March 1, 2003;
63(3):
524 - 531.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Dussault, H.-D. Yoo, M. Lin, E. Wang, M. Fan, A. K. Batta, G. Salen, S. K. Erickson, and B. M. Forman
Identification of an endogenous ligand that activates pregnane X receptor-mediated sterol clearance
PNAS,
February 4, 2003;
100(3):
833 - 838.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hitzl, K. Klein, U. M. Zanger, P. Fritz, A. K. Nussler, P. Neuhaus, and M. F. Fromm
Influence of Omeprazole on Multidrug Resistance Protein 3 Expression in Human Liver
J. Pharmacol. Exp. Ther.,
February 1, 2003;
304(2):
524 - 530.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Goodwin, K. C. Gauthier, M. Umetani, M. A. Watson, M. I. Lochansky, J. L. Collins, E. Leitersdorf, D. J. Mangelsdorf, S. A. Kliewer, and J. J. Repa
Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor
PNAS,
January 7, 2003;
100(1):
223 - 228.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Kliewer, B. Goodwin, and T. M. Willson
The Nuclear Pregnane X Receptor: A Key Regulator of Xenobiotic Metabolism
Endocr. Rev.,
October 1, 2002;
23(5):
687 - 702.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Brendel, K. Schoonjans, O. A. Botrugno, E. Treuter, and J. Auwerx
The Small Heterodimer Partner Interacts with the Liver X Receptor {alpha} and Represses Its Transcriptional Activity
Mol. Endocrinol.,
September 1, 2002;
16(9):
2065 - 2076.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Handschin, M. Podvinec, R. Amherd, R. Looser, J.-C. Ourlin, and U. A. Meyer
Cholesterol and Bile Acids Regulate Xenosensor Signaling in Drug-mediated Induction of Cytochromes P450
J. Biol. Chem.,
August 9, 2002;
277(33):
29561 - 29567.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Makinen, C. Frank, J. Jyrkkarinne, J. Gynther, C. Carlberg, and P. Honkakoski
Modulation of Mouse and Human Phenobarbital-Responsive Enhancer Module by Nuclear Receptors
Mol. Pharmacol.,
August 1, 2002;
62(2):
366 - 378.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wu, C. Xia, J. Meier, S. Li, X. Hu, and D. S. Lala
The Hypolipidemic Natural Product Guggulsterone Acts as an Antagonist of the Bile Acid Receptor
Mol. Endocrinol.,
July 1, 2002;
16(7):
1590 - 1597.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Kliewer and T. M. Willson
Regulation of xenobiotic and bile acid metabolism by the nuclear pregnane X receptor
J. Lipid Res.,
March 1, 2002;
43(3):
359 - 364.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. R. Kast, B. Goodwin, P. T. Tarr, S. A. Jones, A. M. Anisfeld, C. M. Stoltz, P. Tontonoz, S. Kliewer, T. M. Willson, and P. A. Edwards
Regulation of Multidrug Resistance-associated Protein 2 (ABCC2) by the Nuclear Receptors Pregnane X Receptor, Farnesoid X-activated Receptor, and Constitutive Androstane Receptor
J. Biol. Chem.,
January 18, 2002;
277(4):
2908 - 2915.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|